Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
49 Cards in this Set
- Front
- Back
how do calcefied legions develop
|
from TB being latent first
|
|
why are pt taking drugs for rheumotoid arthritis more suceptible for TB infections
|
these drugs are anti-TNF alpha and TNF alpha plays a role in keeping the infection walled off therefore it may result in a disseminated disease
|
|
when is extrapulmonary TB usually seen
|
in those that are immunosuppressed
|
|
what is persistence of TB
|
ability of TB to survive in spite of host defense due to its ability to halt the maturation of phagosome
|
|
what is latency of TB
|
ability of TB to exist in host for years
|
|
what is seen in latent TB
|
positive skin test
calcified legions |
|
what is the mechanism by which TB persists
|
TB will block the fusion of the phagosome and endosome and then also prevent the acidification of the late phagosome via ATPase and also prevent the phagosome from fusing w/ a lysosome all of which allow TB to survive and prevent the phagosome from maturing
|
|
how does the immune response fight a TB infection
|
Th1 cells secrete IFN gamma (typically not given as a treatment) which stimulates the macrophages to finally mature the phagosomes to kill the bug. IFN gamma also stimulates the macrophages to produce TNF alpha which stimulates granuloma formation to help control the spread of TB
|
|
with a skin test how would the bump of a pt w/ HIV look compared to a immunocompetent pt
|
the HIV pt would have a smaller bump
|
|
what are some results that would indicate a TB infections
|
more lymphocytes and monocytes instead of neutrophils
elevated WBC count |
|
how does the Elispot test work
|
antibody mediated test
|
|
Streptomycin is a what line drug
|
2nd line
|
|
what are the unique structural features of mycobacterium
|
mycolic acid, arabinogalactan, lipoarabinose
|
|
what are the first line drugs for treatment of TB
|
isoniazid
ethambutol rifamycins pyrazinamide |
|
what are the properties of Isoniazid
|
prodrug
activated via catalase peroxidase (KatG) |
|
what is the mechanism of action of Isoniazid
|
inhibits mycolic acid synthesis by inhibiting the enzyme enoyl ACP reductase
|
|
what gene encodes for enoyl ACP reductase
|
inhA
|
|
what is the ADME of Isoniazid
|
accumulates in casseous pockets/granulomas of infection
|
|
what are the mechanims of resistance to Isoniazid
|
mutations in katG (which converts it to active drug)
mutations in nhA (which encodes enoly ACP reductase; the drug target) mutation in kasA (participates in mycolic acid synthesis) mutation in ndh |
|
what must be given a long w/ Isoniazid and why
|
pyridoxine (vit B6)
it must be given b/c Isoniazid and its metabolites interfers w/ an enzyme reaction that requires pyridoxine therefore we give pyridoxine to compete w/ Isoniazid |
|
what are the adverse reactions of Isoniazid
|
seizures/CNS effects due to the accumulation of glutamate due to insufficient pyridoxine (B6)
liver damage leading to non infections hepatitis therefore MUST MONITOR LIVER ENZYMES DURING TREATMENT |
|
what populations must be givent pyridoxine
|
diabetics
HIV (immunocompromised) pt on high lvl of isoniazid alcoholics pregnant women |
|
what are the Rifamycins
|
rifampin
rifambutin rifapentine |
|
what are the properties of rifamycines
|
broad spectrum (gram +/-)
bactericidal |
|
what is the mechanism of action of Rifamycins
|
binds to DNA dependent RNA polymerase (DDRP) and forms a complex preventing bacterial transcription
may bind to our mitochondrial DDRP at high concentrations |
|
what is the resistance to Rifamycins
|
mutations in genes that encode bacterial DDRP
|
|
what is the adverse effects of rifamycins
|
may color body fluids, contact lenses w/ a red tint
induces CYPs including CYP3A4 hepatitis may occur (rare) |
|
what are the properties of Rifabutin and Rifapentin
|
Rifabutin has less induction of CYPs so better for HIV patients
Rifapentin is intermediate b/t Rifampin and Rifabutin as far as CYP induction and has a longer t1/2 so greater distance b/t doses |
|
what are the properties of Ethambutol
|
only works on Mycobacteria species
|
|
what is the mechanism of action of ethambutol
|
inhibits arabinosyl transferases that attach arabinosides to cell wall (INHIBITS CELL WALL SYNETHESIS)
|
|
what gene encodes arabinosyl transferases
|
embA
|
|
what is the resistance to Ethambutol
|
mutations in embA gene (encodes for arabinosyl transferase)
target overexpression/gene amplification resulting in a large amount of arabinosyl transferase allowing cell wall synthesis to occur even in the presence of ethambutol |
|
what is the adverse effect of ethambutol
|
toxicity of optic nerve, neuritis resulting in changes in vision
|
|
what are the properties of pyrazinimide
|
prodrug
works on M tuberculosis species only pyrazinoic acid is the active metabolite converted via pyrazinamidase best activity of pyrazinoic acid in acidic environments like phagasomes |
|
what gene encodes pyrazinimidase
|
pncA
|
|
what is the resistance to pyrazinamides
|
mutations in pncA gene therefore no active metabolites formed
|
|
what is the MOA of pyrazinamides
|
inhibits cell wall synthesis by inhibiting fatty acid synthase 1 (isoniazide inhibits fatty acid synthase 2) which is critical for mycolic acid synthesis
|
|
what are the adverse effects of pyrazinamides
|
hepatitis in those w/ liver/hepatic dysfunction therefore monitor liver enzymes
|
|
what drugs can be used to treat latent TB
|
isoniazide
rifamycins |
|
how long does it take someone to feel better when on 4 drug regimen
|
1-2 weeks
|
|
why does Tb antibiotic therapy take so long to work
|
drug persists and becomes latent
|
|
what is MDR
|
Tb resistant to first line anti TB drugs (pyrazinamide, isoniazid, rifamycins, ethambutol)
|
|
what is XDR
|
resistant to MDR and 2nd line anti TB drugs (fluoroquinolones and at least one injectable antibiotic)
|
|
what are the 2nd line drugs
|
ethionamide
aminosalicylic acid cycloserine streptomycin capreomycin amikacin fluoroquinolones linezololid interferon gamma |
|
what does capreomycin do
|
inhibit protein synthesis
|
|
what does streptomycin do
|
aminoglycoside that inhibits protein synthesis
|
|
what does cyclocerine do
|
analog of alanine which is a component of peptidoglycan cell wall
interferes w/ cell wall synethesis |
|
what does aminosalicylic acid do
|
analog of PABA therefore inhibits folate metabolism
|
|
what does ethionamide do
|
inhibit cell wall synthesis same target as isoniazide (enoyl ACP reductase)
|